✨ Medicine Distribution Consents




29 SEPTEMBER 2005

NEW ZEALAND GAZETTE, No. 165

4139

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Colgout

Active Ingredient: Colchicine 0.5mg

Dosage Form: Tablet

New Zealand Sponsor: Anspec New Zealand Limited

Manufacturer: Strides Arcolab Limited, Indlawadi Cross, Anekal Taluk, Bangalore, India

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 26th day of September 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6475

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Actigall

Active Ingredient: Ursodeoxycholic acid 300mg

Dosage Form: Capsule

New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector

Manufacturer: Watson Laboratories Inc, Carmel NY, United States of America

Note: This consent is valid for two years from 7 September 2005.

Dated this 26th day of September 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6471

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Desmopressin PH&T

Active Ingredient: Desmopressin acetate 0.6mg equivalent to desmopressin 0.089mg/mL

Dosage Form: Nasal spray solution

New Zealand Sponsor: AFT Pharmaceuticals Limited

Manufacturer: MIPHARM S.p.A, Milano, Italy

Product: m-cefazolin

Active Ingredient: Cephazolin sodium 2.096g equivalent to cefazolin 2g

Dosage Form: Powder for injection

New Zealand Sponsor: Multichem NZ Limited

Manufacturer: Laboratorio Reig Jofre SA, Sant Adria de Besos, Barcelona, Spain

Product: m-Cefazolin

Active Ingredient: Cephazolin sodium 1.048g equivalent cefazolin 1g

Dosage Form: Powder for injection

New Zealand Sponsor: Multichem NZ Limited

Manufacturers: Laboratorio Reig Jofre SA, Sant Adria de Besos, Barcelona, Spain
Laboratorio Reig Jofre SA, Sant Joan Despi, Barcelona, Spain

Product: m-cefazolin

Active Ingredient: Cephazolin sodium 524mg equivalent to cefazolin 500mg

Dosage Form: Powder for injection

New Zealand Sponsor: Multichem NZ Limited

Manufacturers: Laboratorio Reig Jofre SA, Sant Adria de Besos, Barcelona, Spain
Laboratorio Reig Jofre SA, Sant Joan Despi, Barcelona, Spain

Product: m-Fluconazole

Active Ingredient: Fluconazole 100mg

Dosage Form: Capsule

New Zealand Sponsor: Multichem NZ Limited

Manufacturer: Pharmathen SA, Pallini, Attikis, Greece



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2005, No 165


Gazette.govt.nz PDF NZ Gazette 2005, No 165





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
26 September 2005
Medicines, Distribution, Consent, Medicines Act 1981
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Provisional Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
26 September 2005
Medicines, Provisional Consent, Distribution, Colchicine
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Renewal of Provisional Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
26 September 2005
Medicines, Provisional Consent, Renewal, Ursodeoxycholic acid
  • DON MATHESON, Deputy Director-General, Public Health